$HQL

$17.70 -$0.03 (0.17%) Close

$HQL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 30.4M shares outstanding

Who owns HQL?

By type of holder

Institutions 25.9% Insiders 19.1% Everyone else 55.0%

Concentration Top 10 holders own 22.4%

Morgan Stanley 5.8% · Boaz R. Weinstein 4.8%

Institutional ownership

25.9%

-1.4 pts vs last qtr

Institutional holders

-3 vs last qtr

Net shares bought

−425.0K

by institutions in Q2 2026

New / sold out

9 / 12

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Morgan Stanley +200.8K
Allspring Global Investments Holdings, LLC +92.6K

Biggest sellers in Q2 2026

Saba Capital Management, L.P. −869.3K
Shaker Financial Services, LLC −63.2K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for abrdn Life Sciences Investors in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for abrdn Life Sciences Investors.

How patient are the owners?

Institutional shares by how long they've been held

5+ years52% 3–5 years12% 1–3 years28% Under 1 year8%

Quarterly turnover

12.0%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting HQL on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MS Morgan Stanley	1.8M	5.83%	+200.8K (+12.8%)	≤2021	0.0%
Shares held by quarter Peak holding1.8M (Q2'26) Change over 8 quarters+1.3M Share of the company5.830% Morgan Stanley's full portfolio →
SC Saba Capital Management, L.P. 13D · 5.0%	78.1K	0.26%	−869.3K (−91.8%)	2023	0.0%
Shares held by quarter Peak holding3.4M (Q4'24) Change over 8 quarters−3.4M Share of the company0.260% Disclosed stake13D · 5.0% Saba Capital Management, L.P.'s full portfolio →

Morgan Stanley

1.8M

% of company

5.83%

Change vs last qtr

+200.8K (+12.8%)

Held since

≤2021

Saba Capital Management, L.P.

13D · 5.0%

78.1K

% of company

0.26%

Change vs last qtr

−869.3K (−91.8%)

Held since

2023

28 more super investors behind a free account

See every manager holding abrdn Life Sciences Investors, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting HQL on Form N-PORT; together they hold 4.2% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AC Amplify CEF High Income ETF Amplify ETF Trust	$16.7M	834.9K	2.75%	2.32%	June 30, 2026
RO RiverNorth Opportunities Fund Inc. Rivernorth Opportunities Fund Inc.	$3M	150.0K	0.49%	0.91%	June 30, 2026

Amplify CEF High Income ETF

Amplify ETF Trust

Position value

$16.7M

% of company

2.75%

% of the fund

2.32%

As of

June 30, 2026

RiverNorth Opportunities Fund Inc.

Rivernorth Opportunities Fund Inc.

Position value

$3M

% of company

0.49%

% of the fund

0.91%

As of

June 30, 2026

8 more funds behind a free account

See every fund holding abrdn Life Sciences Investors and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
BR Boaz R. Weinstein 5%+ holder 13D · 5.0%	1.5M	4.81%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company4.810% Disclosed stake13D · 5.0% View the 13D/G filing →
PC Pittard Christian Insider	7.9K	0.03%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.030% Pittard Christian's insider activity →

Boaz R. Weinstein

5%+ holder13D · 5.0%

1.5M

% of company

4.81%

Change vs last qtr

—

Held since

—

Pittard Christian

Insider

7.9K

% of company

0.03%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of abrdn Life Sciences Investors.

Comments